Trade Kura Oncology Inc - KURA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.17 |
| Open | 7.3 |
| 1-Year Change | -50.17% |
| Day's Range | 7.15 - 7.37 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 7.33 | 0.04 | 0.55% | 7.29 | 7.38 | 7.15 |
| Jan 17, 2025 | 7.20 | 0.01 | 0.14% | 7.19 | 7.26 | 7.07 |
| Jan 16, 2025 | 7.12 | -0.01 | -0.14% | 7.13 | 7.18 | 6.96 |
| Jan 15, 2025 | 7.17 | -0.20 | -2.71% | 7.37 | 7.51 | 7.07 |
| Jan 14, 2025 | 7.19 | -0.01 | -0.14% | 7.20 | 7.25 | 7.00 |
| Jan 13, 2025 | 7.18 | 0.02 | 0.28% | 7.16 | 7.20 | 6.93 |
| Jan 10, 2025 | 7.26 | -0.28 | -3.71% | 7.54 | 7.60 | 7.12 |
| Jan 8, 2025 | 7.72 | -0.24 | -3.02% | 7.96 | 8.04 | 7.65 |
| Jan 7, 2025 | 8.12 | -0.21 | -2.52% | 8.33 | 8.52 | 8.08 |
| Jan 6, 2025 | 8.46 | -0.25 | -2.87% | 8.71 | 8.82 | 8.46 |
| Jan 3, 2025 | 8.67 | 0.02 | 0.23% | 8.65 | 8.78 | 8.55 |
| Jan 2, 2025 | 8.62 | -0.04 | -0.46% | 8.66 | 8.80 | 8.57 |
| Dec 31, 2024 | 8.66 | 0.16 | 1.88% | 8.50 | 8.67 | 8.44 |
| Dec 30, 2024 | 8.45 | -0.13 | -1.52% | 8.58 | 8.59 | 8.37 |
| Dec 27, 2024 | 8.62 | -0.26 | -2.93% | 8.88 | 8.94 | 8.58 |
| Dec 26, 2024 | 8.92 | 0.20 | 2.29% | 8.72 | 9.01 | 8.70 |
| Dec 24, 2024 | 8.76 | -0.04 | -0.45% | 8.80 | 8.95 | 8.69 |
| Dec 23, 2024 | 8.88 | -0.08 | -0.89% | 8.96 | 8.97 | 8.70 |
| Dec 20, 2024 | 8.96 | 0.16 | 1.82% | 8.80 | 9.08 | 8.80 |
| Dec 19, 2024 | 8.91 | -0.19 | -2.09% | 9.10 | 9.18 | 8.79 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Kura Oncology Inc Company profile
About Kura Oncology Inc
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company’s segment is engaged in discovery and development of medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. It is developing its lead product candidate, tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and hematologic indications. It is developing KO-539, a small molecule inhibitor of the Lysine K-specific Methyltransferase 2A (KMT2A) interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Kura Oncology Inc revenues was not reported. Net loss increased 46% to $130.5M. Higher net loss reflects General and administrative - Balancing increase of 35% to $30.4M (expense), Stock-based Compensation in SGA increase of 82% to $16.1M (expense), Share-based compensation increase of 88% to $7.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.69 to -$1.97.
| Industry: | Bio Therapeutic Drugs |
12730 High Bluff Drive, Suite 400
SAN DIEGO
CALIFORNIA 92130
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com